Variation in opioid analgesia administration and discharge prescribing for emergency department patients with suspected urolithiasis.
Variation in opioid analgesia administration and discharge prescribing for emergency department patients with suspected urolithiasis.
复制标题
DOI:
10.1016/j.ajem.2020.07.016
复制
发表时间:
2020-10
期刊:
影响因子:
--
通讯作者:
Merchant RC
中科院分区:
文献类型:
--
作者:
Wentz AE;Wang RRC;Marshall BDL;Shireman TI;Liu T;Merchant RC
Previous research has suggested caution about opioid analgesic usage in the emergency department (ED) setting and raised concerns about variations in prescription opioid analgesic usage, both across institutions and for whom they are prescribed. We examined opioid analgesic usage in ED patients with suspected urolithiasis across fifteen participating hospitals. This secondary analysis of a clinical trial including adult ED patients with suspected urolithiasis. In multilevel models accounting for clustering by hospital, we assessed demographic, clinical, state-level, and hospital-level factors associated with opioid analgesic administration during the ED visit and prescription at discharge. Of 2,352 participants, 67% received an opioid analgesic during the ED visit and 61% were prescribed one at discharge. Opioid analgesic usage varied greatly across hospitals, ranging from 46% to 88% (during visit) and 34% to 85% (at discharge). Hispanic patients were less likely than non-Hispanic white patients to receive opioid analgesics during the ED visit (OR 0.72, 95% CI 0.55–0.94). Patients with higher education (OR 1.29, 95% CI 1.05–1.59), health insurance coverage (OR 1.27, 95% CI 1.02–1.60), or receiving care in states with a prescription drug monitoring program (OR 1.64, 95% CI 1.06–2.53) were more likely to receive an opioid analgesic prescription at ED discharge. We found marked hospital-level differences in opioid analgesic administration and prescribing, as well as associations with education, healthcare insurance, and race/ethnicity groups. These data might compel clinicians and hospitals to examine their opioid use practices to ensure it is congruent with accepted medical practice.
登录
查看更多内容
影响因子:
3
作者:
Shah, Adil A.;Zogg, Cheryl K.;Haider, Adil H.
通讯作者:
Haider, Adil H.
影响因子:
3.6
作者:
Mills, Angela M.;Shofer, Frances S.;Abbuhl, Stephanie B.
通讯作者:
Abbuhl, Stephanie B.
影响因子:
6.2
作者:
Hoppe, Jason A.;Nelson, Lewis S.;Weiner, Scott G.
通讯作者:
Weiner, Scott G.
影响因子:
120.7
作者:
Pletcher, Mark J.;Kertesz, Stefan G.;Gonzales, Ralph
通讯作者:
Gonzales, Ralph
影响因子:
33.9
作者:
Guy, Gery P., Jr.;Zhang, Kun;Dowell, Deborah
通讯作者:
Dowell, Deborah